We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Oxford Metrics Plc | LSE:OMG | London | Ordinary Share | GB0030312788 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 113.00 | 111.00 | 115.00 | 113.00 | 113.00 | 113.00 | 57,476 | 07:30:32 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Computers & Software-whsl | 44.24M | 5.66M | 0.0430 | 26.28 | 148.51M |
Date | Subject | Author | Discuss |
---|---|---|---|
17/10/2009 13:57 | i think some investors got mixed up, put their money in ODX( Omega Dia) by mistake. | abbey8 | |
17/10/2009 10:35 | well done chillichap, it is good news. | abbey8 | |
17/10/2009 08:50 | I would imagine the defense industry will be particularly interested. | chillichap | |
16/10/2009 20:25 | Nice movement up today. There will be more press coverage as applications for the Revue are revealed. It has the weight of Microsoft behind it, so expect it to be a success. | chillichap | |
16/10/2009 12:13 | good prospect in the days and months to come. | abbey8 | |
16/10/2009 08:28 | Morning Abbey, I have not seen anything, but Im sure it will have got a mention some where. This is one to try and be patient with I reckon, very limited downside, and huge potential upside, just take a look at that longterm chart above, the share price was 60p just over 12 months ago, and since then there have been new product launces, and now the IP licence with Microsoft!!! Tick up I see 8-) | eggbird | |
16/10/2009 07:53 | good morning , any mention in the papers today? | abbey8 | |
15/10/2009 19:26 | With so many different applications, the wearable personal camera could become one of the biggest 'must have' gadgets of 2010. | chillichap | |
15/10/2009 19:04 | Good articles smarkmmm. Quite appealing to the world of social media I'd say too. | chillichap | |
15/10/2009 18:50 | Demand could be huge: Picture of Vicon's product 'Revue' at: | smarkmmm | |
15/10/2009 18:22 | The camera is going to be shown off this weekend ;) | chillichap | |
15/10/2009 17:56 | New products and new contract wins coming up. OMG know exactly what this technology will be used for. Microsoft aren't going to let just anyone use their product. Expect to see news regarding its application soon. | chillichap | |
15/10/2009 14:26 | Surely they should tell us either way to enhance their image. | abbey8 | |
15/10/2009 13:08 | Abbey, OMG licensing FROM Microsoft. The question is how much OMG have PAID and what the potential market size is. Is it conceived mainly as a way of enhancing and leveraging existing technology & products (eg. Yotta?) or are they developing a whole new family of products? G. | garth | |
15/10/2009 09:24 | Hi, just got in with 10000 shares, how much the contract is worth future wise. Thanks | abbey8 | |
15/10/2009 09:13 | been watching these for a while - this is big, gratz to all holders | chillichap | |
15/10/2009 09:06 | Microsoft deal!! 15 October 2009 OMG plc ("OMG" or the "Group") IP License Agreement with Microsoft - Vicon signs license agreement with Microsoft to develop new medical technology - OMG plc, Oxford Metrics Group (LSE: OMG), ("OMG" or "the Group") the technology group providing image understanding products for the entertainment, defence, life science and engineering industries announced today that it has signed an intellectual property ("IP") license agreement with Microsoft Corp. The agreement will allow the Group's Vicon arm, which develops motion capture products for the life science, engineering and entertainment industries, to manufacture and sell devices incorporating Microsoft's SenseCam technology worldwide. SenseCam is a wearable digital camera that takes photographs automatically, without user intervention. Developed by Microsoft Research Cambridge, the device is most commonly used by medical researchers as an aid for people with memory loss, but has great potential in a number of different application areas. Research into these areas will be possible now that it will be more widely available. Vicon will unveil a new device, which is based on the existing SenseCam technology on its stand #1413 at the annual Neuroscience Conference in Chicago on 17-21 October. Ahead of the device launch OMG plc Chief Executive Officer, Nick Bolton, said: "I'd like to thank Microsoft and Microsoft Research Cambridge for allowing Vicon to get involved in such an important product that can support a variety of researchers, including those investigating memory-loss. It's an honour to work with Microsoft and to build on the amazing work they have done with SenseCam over the past five years. "This IP license agreement means we're the first company to be able to deliver Microsoft's ground breaking technology to a wider audience. All of us at OMG look forward to working closely with Microsoft and the researchers that have been using SenseCam Project technology and continuing to move it forward." Andrew Herbert, Distinguished Engineer and Managing Director, Microsoft Research Cambridge said: "Microsoft's willingness to license intellectual property arising from its research enables partner companies to bring innovative products to market. This agreement represents the next stage in the life of SenseCam and will bring the device to a broader community." | eggbird | |
06/10/2009 08:51 | I looks as if there is a bigish seller that keeps selling 10-40k chunks when there is no buyers around. The underlying business still seems to perform reasonably considering the economy. It needs a breakthrough with a decent size defence contract to kickstart the share price. | geovest | |
05/10/2009 17:35 | Any idea what's going on here? The market has recovered considerably from its March lows and yet this is back where it was in March. Now OMG is worth less than half of annual revenue! Seems a bit ridiculous to me. | bbonsall | |
08/9/2009 23:45 | with gbp18 nav looks like a steal to me, will buy some tomorrow | empirestate | |
07/9/2009 13:02 | Quiet around here. Everyone still on hols? | mctmct | |
05/8/2009 16:09 | Thank you for that link. Growthcompany Investor have got their figures round their neck I think, or is it Evolution? The trouble is, it is grossly misleading and could cause a share price collapse. They say full year forecast eps is 0.9p and so PE ratio is 28.9. OMG made 0.9p eps in the first half alone, so is it expected to make no profit at all in the second half? I think not. Ridiculous! Evolution may mean OMG will make a further 0.9p eps in the second half, so giving a total of 1.8p for the full year and a more modest forward PE of 14.5. I have seen this sort of mathematical misunderstanding before from experts who should know better and think before disseminating false analysis on which investors might be persuaded to act. I have seen them in other cases using half year eps as though it is for a full year and then commenting that a share price is too high etc. | bbonsall | |
04/8/2009 12:04 | Speculative Buy rating from Growth Company Investor | investinggarden |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions